Article
While complication rates for chemical peels that havebeen described in the literature are low enough so that the risk:benefitratios are good
2024 Drug Approvals in Review: Part 1
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Dermatology Times 2024 in Review: Psoriasis
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Phase 3 Trials Confirm Deucravacitinib’s Efficacy in PsA
Derm In The News: 2024